Genmab (GMAB) SEC filings

6-K

GMAB Genmab

18 May 22

Current report (foreign)

10:52am

6-K

GMAB Genmab

17 May 22

Capital Increase in Genmab as a Result of Employee Warrant Exercise

2:39pm

6-K

GMAB Genmab

11 May 22

Genmab Announces Financial Results for the First Quarter of 2022

11:24am

6-K

GMAB Genmab

19 Apr 22

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2022

8:08am

6-K

GMAB Genmab

13 Apr 22

Current report (foreign)

5:28pm

6-K

GMAB Genmab

7 Apr 22

Genmab Announces the Initial Resolution of its Arbitration with Janssen Relating to their Daratumumab License Agreement

8:09pm

6-K

GMAB Genmab

7 Apr 22

Current report (foreign)

9:23am

6-K

GMAB Genmab

29 Mar 22

Current report (foreign)

2:58pm

6-K

GMAB Genmab

29 Mar 22

Passing of Genmab A/S’ Annual General Meeting

9:37am

6-K

GMAB Genmab

14 Mar 22

Genmab Announces the Nomination of a New Member of the Company’s Board of Directors

9:58am

6-K

GMAB Genmab

9 Mar 22

Current report (foreign)

10:14am

6-K

GMAB Genmab

25 Feb 22

Current report (foreign)

4:35pm

S-8

GMAB Genmab

24 Feb 22

Registration of securities for employees

4:35pm

6-K

GMAB Genmab

24 Feb 22

Notice to Convene the Annual General Meeting of Genmab A/S

9:15am

6-K

GMAB Genmab

23 Feb 22

Current report (foreign)

11:28am

6-K

GMAB Genmab

22 Feb 22

Capital Increase in Genmab as a Result of Employee Warrant Exercise

2:21pm

20-F

2021 FY

GMAB Genmab

16 Feb 22

Annual report (foreign)

1:56pm

6-K

GMAB Genmab

16 Feb 22

Genmab 2021 Annual Report

11:29am

6-K

GMAB Genmab

3 Feb 22

Current report (foreign)

10:18am

SC 13G/A

BLK Blackrock Inc.

2 Feb 22

GENMAB A/S / BlackRock ownership change

7:00pm